Published in Front Aging Neurosci on June 03, 2016
Neuroinflammation Induces Neurodegeneration. J Neurol Neurosurg Spine (2016) 0.76
Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction. Int J Mol Sci (2017) 0.75
LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-β1 inhibition. Am J Transl Res (2017) 0.75
Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease. Int J Mol Sci (2016) 0.75
Eburicoic acid from Laetiporus sulphureus (Bull.:Fr.) Murrill attenuates inflammatory responses through inhibiting LPS-induced activation of PI3K/Akt/mTOR/NF-κB pathways in RAW264.7 cells. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration. Surg Neurol Int (2017) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Immunity, inflammation, and cancer. Cell (2010) 28.27
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet (2004) 14.31
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 7.55
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
Caspase signalling controls microglia activation and neurotoxicity. Nature (2011) 3.44
Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci (2003) 2.91
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet (2009) 2.51
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis (2009) 2.49
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol (2004) 2.45
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 2.05
The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One (2008) 1.99
Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet (2002) 1.88
Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (1996) 1.73
Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet (2003) 1.60
Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology (2011) 1.45
Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J Neurosci (2011) 1.36
Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res (2003) 1.34
Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer (2000) 1.32
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions. Expert Opin Investig Drugs (2009) 1.28
Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int J Cancer (1999) 1.20
Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther (2001) 1.18
Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma. PLoS One (2010) 1.17
Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res (2003) 1.17
IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease. Biomed Pharmacother (1999) 1.15
Silencing of the UCHL1 gene in human colorectal and ovarian cancers. Int J Cancer (2006) 1.15
The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clin Cancer Res (2010) 1.13
Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2002) 1.10
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci U S A (2011) 1.05
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism Relat Disord (2003) 1.05
Consequences of DJ-1 upregulation following p53 loss and cell transformation. Oncogene (2011) 0.99
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res (2006) 0.95
Problem situations in the treatment of paralysis agitans. J Am Med Assoc (1954) 0.94
Misfolded α-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease. Parkinsonism Relat Disord (2012) 0.93
Common pathogenic pathways in melanoma and Parkinson disease. Neurology (2010) 0.92
Role of NOD2 variants in spondylarthritis. Arthritis Rheum (2002) 0.91
PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol (2010) 0.90
Parkinson's disease and cancer: insights for pathogenesis from epidemiology . Ann N Y Acad Sci (2009) 0.87
Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma Res (2006) 0.86
alpha-Synuclein is expressed in a variety of brain tumors showing neuronal differentiation. Acta Neuropathol (2000) 0.86
[NOD2/CARD15 gene polymorphisms and susceptibility to Crohn's disease in Chinese Han population]. Zhonghua Nei Ke Za Zhi (2005) 0.85
P268S in NOD2 associates with susceptibility to Parkinson's disease in Chinese population. Behav Brain Funct (2013) 0.84
CARD15 variants in patients with sporadic Parkinson's disease. Neurosci Res (2006) 0.83
Genetic predisposition to Parkinson's disease and cancer. Curr Cancer Drug Targets (2014) 0.79
The Parkinson's disease market. Nat Rev Drug Discov (2011) 0.78
NOD2 and colorectal cancer: guilt by non-association. Cancer Res (2004) 0.76
Genetic association of cyclooxygenase-2 gene polymorphisms with Parkinson's disease susceptibility in Chinese Han population. Int J Clin Exp Pathol (2015) 0.76
Herba Cistanche (Rou Cong-Rong): One of the Best Pharmaceutical Gifts of Traditional Chinese Medicine. Front Pharmacol (2016) 0.84